Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

09 January 2002

NOC/oFQ activates PKC and generates superoxide to impair hypotensive cerebrovasodilation after hypoxia/ischemia.

William Armstead

Med Sci Monit 2002; 8(1): BR :: ID: 420978

Abstract

BACKGROUND: Previous studies have observed that hypotensive pial arterydilation was blunted following global cerebral ischemia in the piglet. In unrelated studies, superoxide(O-2) contributed to impaired hypotensive cerebrovasodilation following traumatic brain injury in therat while the opioid nociceptin/orphanin FQ (NOC/oFQ) generated O-2 via activation of protein kinaseC in the piglet. This study determined the contribution of NOC/oFQ, PKC activation and O-2 generationin hypoxic ischemic hypotensive cerebrovasodilation impairment.Material/Methods: Anesthetized newbornpigs equipped with a closed cranial window were used. Global cerebral ischemia was produced via elevatedintracranial pressure. Hypoxia, via inhalation of nitrogen, decreased PO2 to 34I3 mmHg. RESULTS: TopicalNOC/oFQ (10-10M), the CSF concentration following hypoxia/ischemia, had no effect on pial artery diameterby itself but attenuated hypotension (mean arterial blood pressure decrease of 44I2%) induced pial arterydilation (33I1 vs 19I2%). Coadministration of the PKC inhibitor chelerythrine (10-7M) or the O-2 scavengerpolyethylene glycol superoxide dismutase and catalase (SODCAT) with NOC/oFQ (10-10M) partially preventedhypotensive pial dilation impairment (34I2 vs 28I1% for SODCAT). Hypotensive pial artery dilation wasblunted by hypoxia/ischemia but such dilation was partially protected by the NOC/oFQ receptor antagonist[F/G] NOC/oFQ (1-13) NH2 (10-6M), chelerythine or SODCAT (34I1 vs 7I2 vs 21I2% for sham, H/I and H/I+ SODCAT, respectively). CONCLUSIONS: These data show that PKC activation and generation of O-2 contributesto hypoxia/ischemia impairment of hypotensive pial artery dilation. These data suggest that NOC/oFQ activatesPKC and generates O-2 to impair hypotensive cerebrovasodilation after hypoxia/ischemia.

Keywords: Animals, Newborn, Anoxia, Arteries, Brain, Ischemia, Models, Biological, Opioid Peptides, Oxygen, Pressure, Protein Kinase C, Research Support, Non-U.S. Gov, Research Support, U.S. Gov, Superoxides, Swine, Time Factors, Vasodilation

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750